Literature DB >> 12616091

Coagulopathies and arterial stroke.

Mark L Moster1.   

Abstract

Although hypercoagulable states are most often associated with venous thrombosis, arterial thromboses are reported in protein S, protein C, and antithrombin III deficiencies, factor V Leiden and prothrombin gene mutations, hyperhomocysteinemia, dysfibrinogenemia, plasminogen deficiency, sickle cell disease, and antiphospholipid antibody syndrome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12616091     DOI: 10.1097/00041327-200303000-00012

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  16 in total

1.  Role of FLAP and PDE4D in myocardial infarction and stroke: target discovery and future treatment options.

Authors:  Hakon Hakonarson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

Review 2.  Neurological and Neurosurgical Emergencies in Patients with Hematological Disorders.

Authors:  Martha L Cruz; Shama Farooq; Fernando D Testai
Journal:  Curr Neurol Neurosci Rep       Date:  2017-03       Impact factor: 5.081

Review 3.  Hypercoagulable states and strokes.

Authors:  Nena Matijevic; Kenneth K Wu
Journal:  Curr Atheroscler Rep       Date:  2006-07       Impact factor: 5.113

4.  Novel association of a PROC variant with ischemic stroke in a Chinese Han population.

Authors:  Xuan Lu; Liang Tang; Kang Xu; Jie Ma; Tao Guo; Heng Mei; Rui Yang; Jianming Yu; Qingyun Wang; Yan Yang; Xiaorong Jian; Yu Hu
Journal:  Hum Genet       Date:  2012-09-14       Impact factor: 4.132

Review 5.  Ischaemic stroke in young adults: risk factors and long-term consequences.

Authors:  Noortje A M M Maaijwee; Loes C A Rutten-Jacobs; Pauline Schaapsmeerders; Ewoud J van Dijk; Frank-Erik de Leeuw
Journal:  Nat Rev Neurol       Date:  2014-04-29       Impact factor: 42.937

6.  Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism.

Authors:  Cihangir Erem; Ozge Ucuncu; Mustafa Yilmaz; Mustafa Kocak; Irfan Nuhoglu; Halil Onder Ersoz
Journal:  Endocrine       Date:  2008-10-29       Impact factor: 3.633

7.  Prevalence of resistence to activated protein C (APC-resistance) in blood donors in Kosovo.

Authors:  Ymer Mekaj; Bukurije Zhubi; Hakif Hoxha; Remzije Belegu; Agon Mekaj; Ermira Miftari; Mazllum Belegu
Journal:  Bosn J Basic Med Sci       Date:  2009-11       Impact factor: 3.363

8.  The prevention of pain from sickle cell disease by trandolapril.

Authors:  R Michael Williams; David W Moskowitz
Journal:  J Natl Med Assoc       Date:  2007-03       Impact factor: 1.798

9.  Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism.

Authors:  Cihangir Erem; Ozge Ucuncu; Mustafa Yilmaz; Mustafa Kocak; İrfan Nuhoglu; Halil Onder Ersoz
Journal:  Endocrine       Date:  2009-10-27       Impact factor: 3.633

Review 10.  Cryptogenic stroke: how to define it? How to treat it?

Authors:  Ava L Liberman; Shyam Prabhakaran
Journal:  Curr Cardiol Rep       Date:  2013-12       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.